14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $11.01 $14.21 Friday, 3rd May 2024 IOVA stock ended at $13.63. This is 5.82% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.36% from a day low at $13.30 to a day high of $13.88.
90 days $7.62 $18.33
52 weeks $3.21 $18.33

Historical Iovance Biotherapeutics, Inc. prices

Date Open High Low Close Volume
Aug 23, 2023 $6.41 $6.53 $6.30 $6.31 3 341 678
Aug 22, 2023 $6.34 $6.42 $6.19 $6.38 2 616 592
Aug 21, 2023 $6.12 $6.38 $6.00 $6.29 2 868 757
Aug 18, 2023 $6.20 $6.32 $6.06 $6.07 3 247 207
Aug 17, 2023 $6.91 $6.96 $6.22 $6.27 7 928 849
Aug 16, 2023 $7.40 $7.78 $6.84 $6.90 8 905 471
Aug 15, 2023 $7.04 $7.55 $6.90 $7.51 7 351 346
Aug 14, 2023 $7.06 $7.28 $6.95 $7.12 4 464 629
Aug 11, 2023 $7.13 $7.18 $6.80 $7.06 4 199 093
Aug 10, 2023 $7.58 $7.58 $7.00 $7.19 5 774 663
Aug 09, 2023 $7.09 $7.93 $7.06 $7.60 7 447 756
Aug 08, 2023 $7.04 $7.26 $6.98 $7.14 3 686 677
Aug 07, 2023 $7.26 $7.31 $7.00 $7.05 4 723 327
Aug 04, 2023 $7.20 $7.42 $7.11 $7.24 2 811 628
Aug 03, 2023 $7.20 $7.46 $7.12 $7.23 3 583 042
Aug 02, 2023 $7.10 $7.23 $6.95 $7.18 4 421 887
Aug 01, 2023 $7.22 $7.25 $7.06 $7.19 2 862 773
Jul 31, 2023 $7.20 $7.39 $7.16 $7.26 3 097 025
Jul 28, 2023 $7.10 $7.26 $7.05 $7.20 3 198 588
Jul 27, 2023 $7.10 $7.17 $6.97 $7.03 3 771 997
Jul 26, 2023 $7.11 $7.29 $6.99 $7.05 5 156 022
Jul 25, 2023 $7.33 $7.39 $7.05 $7.09 3 674 020
Jul 24, 2023 $7.62 $7.68 $7.31 $7.37 2 938 045
Jul 21, 2023 $7.64 $7.73 $7.41 $7.67 3 320 719
Jul 20, 2023 $7.76 $7.87 $7.60 $7.62 3 602 462
Click to get the best stock tips daily for free!

About Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics. Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or pers... IOVA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT